Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by Nanfang Hospital of Southern Medical University
Sponsor:
Collaborators:
Sun Yat-sen University
Peking University People's Hospital
Guangdong General Hospital
Guangzhou General Hospital of Guangzhou Military Command
Southern Medical University, China
Third Affiliated Hospital, Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou First Municipal People’s Hospital
Guangdong Provincial People's Hospital
Information provided by (Responsible Party):
Nanfang Hospital of Southern Medical University
ClinicalTrials.gov Identifier:
NCT01765660
First received: January 5, 2013
Last updated: January 8, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)